Lopinavir
- 1 May 2003
- journal article
- research article
- Published by Wolters Kluwer Health in AIDS
- Vol. 17 (7) , 1092-1094
- https://doi.org/10.1097/00002030-200305020-00023
Abstract
No abstract availableThis publication has 9 references indexed in Scilit:
- Clinical Implications of CNS Penetration of Antiretroviral DrugsCNS Drugs, 2002
- Ritonavir induces P-glycoprotein expression, multidrug resistance-associated protein (MRP1) expression, and drug transporter-mediated activity in a human intestinal cell lineJournal of Pharmaceutical Sciences, 2001
- Cytokines influence mRNA expression of cytochrome P450 3A4 and MDRI in intestinal cellsJournal of Pharmaceutical Sciences, 2001
- Induction of P-glycoprotein expression by HIV protease inhibitors in cell cultureAIDS, 2000
- Modulation of P-glycoprotein function in human lymphocytes and Caco-2 cell monolayers by HIV-1 protease inhibitorsAIDS, 1999
- HIV protease inhibitor ritonavir: a more potent inhibitor of P-glycoprotein than the cyclosporine analog SDZ PSC 833Biochemical Pharmacology, 1999
- ABT-378, a Highly Potent Inhibitor of the Human Immunodeficiency Virus ProteaseAntimicrobial Agents and Chemotherapy, 1998
- HIV-1 Protease Inhibitors Are Substrates for theMDR1 Multidrug TransporterBiochemistry, 1998
- Active apical secretory efflux of the HIV protease inhibitors saquinavir and ritonavir in Caco-2 cell monolayers.Pharmaceutical Research, 1998